# Food responsiveness, addiction, and hyperphagia in Prader-Willi syndrome: a cross-sectional study of 210 Chinese patients

## TL;DR

This study examines eating behaviors and food addiction in 210 Chinese Prader-Willi syndrome patients, finding abnormal eating patterns and high food addiction risks.

## Contribution

The study identifies food responsiveness and growth hormone therapy as key factors influencing hyperphagia and weight in Prader-Willi syndrome.

## Key findings

- Patients with PWS show abnormal eating behaviors and a high risk of food addiction.
- Higher food responsiveness is linked to increased food addiction risk.
- Growth hormone therapy is beneficial for weight maintenance but does not improve food responsiveness.

## Abstract

Prader–Willi syndrome (PWS) is the most common genetic syndromic obesity, characterized primarily by hyperphagia. It was described as excessive appetite, defective satiety, and obsession with food. However, the underlying mechanisms of hyperphagia in PWS remain obscure. This study aimed to determine the eating behavior patterns and food addiction tendencies in patients with PWS.

210 patients with PWS from 26 provinces in China were enrolled in this study. The translated Children’s Eating Behavior Questionnaire and modified Yale Food Addiction Scale for Children 2.0 were adopted for evaluation.

This study revealed that (i) In patients with PWS, the eating behavior patterns are abnormal and the risk of food addiction is high. (ii) Patients with higher food responsiveness (FR) have a higher risk of food addiction; (iii) Scores of food responsiveness, enjoyment of food, satiety response, and food addiction have already changed even before the onset of overweight or obesity. (iv) Growth hormone (GH) therapy is an independent factor influencing weight, with continuous treatment being beneficial for weight maintenance and earlier treatment being more advantageous. (v) FR is another key factor affecting body weight. Unfortunately, GH therapy does not improve food responsiveness.

This study indicates that GH treatment and FR are significant factors influencing hyperphagia and body weight in patients with PWS. Early involvement of psychotherapeutic interventions may help patients better manage hyperphagia-related behaviors and subsequent weight gain.